- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Rally Could 'Have Some Legs in 2010': Market Strategist
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- US Home Prices Up 5th Month, 2nd Straight Quarter
- China Eastern to Complete Shanghai Air Buy by End '09
- Gold Will Collapse Like Oil Did in 2008: Charts
- Weak Dollar Is Golden for Mining Companies
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- Wave of Debt Payments Facing US Government
- CA "More Profitable" After Saving Energy: CEO
- How Many US Consumers Will Shop this Weekend?
- Behind The Scenes With Warren Buffett
- 'Why the American Consumer Will Keep on Buying No Matter What'
- On Assignment: Europe & Asia
- The L.A. Extravaganza: A Test for Auto Shows
- 8 Stocks That Could Gain With Rising GDP
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- US Home Prices Up 5th Month, 2nd Straight Quarter
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- FDIC Insurance Fund Falls to Negative $8.2 Billion
- Ron Paul's Plan to Audit Fed a 'Serious Attack': Mishkin
- US Economy Mired in 'Form of Depression': Rosenberg
- Strong Banks, Weak Credit: Treasury Rethinks TARP
- Fairfax Lawsuit Keeps Heat on Chanos, SAC's Cohen
- Weak Dollar Is Golden for Mining Companies
- How Many US Consumers Will Shop this Weekend?
RSS FEED
CNBC Stock Blog
Options action on Watson Phamaceuticals [WPI
Loading...
()
]indicates that traders think it might be a takeover target, according to one options experts.
"This is an interesting stock because it has landed in the cross-hairs of very eager call buyers previously on speculation that it might make an attractive takeover target," said Rebecca Darts of Interactive Brokers said Thursday morning on CNBC's "Squawk Box." "Most recently, we saw this back on July 21, in the wake of Teva's [TEVJF
Loading...
()
] takeover of Barr Pharmaceuticals [BRL
Loading...
()
], but yesterday, with shares in Watson trading flat, we saw call volume hit a 52-week high, sending overall volume to about 14 times the normal volume."
Calls, which the buyer an option to buy a stock at a particular strike price in the future, are very active, she indicated.
"During the past month, call open interest -- which is the number of open call position contracts to buy Watson stock -- has increased 77 percent, so that tells us there's a rising litany of bulls on Watson Pharmaceuticals, and this is going to be an interesting stock to watch, even though there's not a specific rumor right now."








